ArticleTheranostics2018

A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.

Lingling Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.